secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0000012208-26-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve Amended 2017 Incentive Award Plan, adding 335,000 shares
-----------------------------------------------------------------------------

- Plan approved with 6.85M for, 105k against; extends expiration to March 18, 2036.
- Increases share reserve by 335,000 shares for future equity grants.
- Stockholder proposal on dual-class capital structure defeated (1.47M for, 5.46M against).
- All six director nominees elected; KPMG ratified as auditors for FY 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/0000012208-26-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220826000024/bio-20260421.htm
  HTML page:      https://secwatch.observer/filing/0000012208-26-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer